CoChat

Medical prescriptions falsified by the patients: a 12‐year national monitoring to assess prescription drug diversion

Jouanjus, Emilie, Guernec, Grégory, Lapeyre‐Mestre, Maryse, the French Addictovigilance Network · 2018 · Fundamental & Clinical Pharmacology
Cited by 61

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Diversion of prescription drugs is difficult to assess in quality and quantity. This study aimed to characterize diversion of prescription drugs in France through a comparative analysis of falsified prescriptions collected during three periods from 2001 to 2012. The data recorded in a national program which records all falsified prescriptions presented to community pharmacies were studied. Included data regarded: subjects, prescription forms, and drugs. Description of the dataset in three periods (2001–2004, 2005–2008, and 2009–2012) was completed with clustering analyses to characterize profiles of prescriptions and subjects associated with the most reported drugs. The 4469 falsified prescriptions concerned most often females (51.6%). Average age was 46.5 years. Zolpidem, bromazepam, and buprenorphine were the most frequent drugs. Alone, 13 drugs (1.7%, 13/772) represented more than 40% of the total reports (3055/7272). They were associated with three diversion profiles: (i) buprenorphine, flunitrazepam, and morphine were mentioned on overlapping secure prescription forms presented by young men; (ii) alprazolam, bromazepam, zolpidem, codeine/acetaminophen were mentioned on simple prescription forms presented by experienced women; and (iii) acetaminophen and lorazepam were mentioned on modified prescription forms presented by elderly subjects. Clonazepam, clorazepate, dextropropoxyphene, zopiclone moved between those profiles. The patterns of falsified prescriptions provided in this study contribute to enhance the scientific knowledge on the most diverted prescription drugs. The latter follow distinct trajectories across time depending on their pharmacology (including their abuse/addiction potential) and on their regulation's history. The close and continuous analysis of falsified prescriptions is an excellent way to monitor prescription drug diversion.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/fcp.12356

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 45

  1. 10.1038/clpt.2010.154 · DOI · Paper page
  2. 10.1097/AJP.0000000000000021 · DOI · Paper page
  3. 10.1186/2197-1714-1-9 · DOI
  4. 10.2105/AJPH.2014.301966 · DOI · Paper page
  5. 10.1002/pds.3711 · DOI · Paper page
  6. 10.1016/j.socscimed.2014.10.016 · DOI
  7. 10.1186/s40621-017-0118-7 · DOI
  8. 10.1111/j.1472-8206.2011.00950.x · DOI
  9. 10.1007/s40264-016-0497-7 · doi:10.1007/s40264-016-0497-7
  10. 10.1007/s002280050246 · DOI
  11. 10.1007/s00228-001-0412-7 · DOI
  12. 10.2165/00002018-200730030-00007 · DOI
  13. 10.1159/000356812 · DOI
  14. 10.1111/j.1472-8206.2010.00882.x · DOI
  15. Nordmann S., 2013, Doctor shopping reveals geographical variations in opioid abuse, Pain Physician, 16, 89
  16. 10.1159/000346179 · DOI
  17. 10.2515/therapie/2015012 · DOI
  18. 10.2515/therapie/2014221 · doi:10.2515/therapie/2014221
  19. 10.1214/aos/1176344552 · DOI · Paper page
  20. 10.1016/j.csda.2007.09.023 · DOI · Paper page
  21. 10.1017/S0305004100013517 · DOI · Paper page
  22. 10.18637/jss.v025.i01 · DOI · Paper page
  23. R Development Core Team, R: a language and environment for statistical computing
  24. American psychiatric association (APA), 2013, Diagnostic and statistical manual of mental disorders (DSM‐5), 991, 10.1176/appi.books.9780890425596 · DOI · Paper page
  25. 10.2515/therapie/2015009 · DOI
  26. Daveluy A., 2018, Tamper‐resistant prescription forms for narcotics in France:should we generalise them? Fundam, Clin. Pharmacol.
  27. 10.1111/fcp.12024 · DOI
  28. 10.1002/pds.4123 · DOI
  29. 10.1016/j.euroneuro.2015.07.006 · DOI
  30. 10.1111/pme.12391 · DOI
  31. 10.1177/0269881112471155 · DOI
  32. 10.5694/mja12.10986 · DOI
  33. Rigg K.K., 2012, Patterns of prescription medication diversion among drug dealers, Drugs (Abingdon Engl.), 19, 144
  34. 10.2515/therapie:2003069 · DOI
  35. 10.2165/11531570-000000000-00000 · DOI
  36. ANSM : Agence nationale de sécurité du médicament et des produits de santé.Arret de commercialisation Rohypnol (flunitrazepam) [Internet]. 2013 [last accessed 26/12/2017]. Available from: file:///C:/Users/jouanjus/AppData/Local/Temp/pi‐130419‐Rohypnol.pdf · doi:10.1016/j.jpp.2012.10.003
  37. 10.1007/s00228-014-1783-x · DOI
  38. 10.1159/000377628 · DOI
  39. 10.1097/YIC.0b013e32834967e5 · DOI
  40. Rubio González V., 2016, Hospital emergencies associated with the consumption of hypnotics and sedatives, 2009–2013, Castilla y León, Spain, Rev. Esp. Salud Publica, 90, e1
  41. 10.1080/10826084.2016.1201509 · doi:10.1080/10826084.2016.1201509
  42. 10.1111/fcp.12210 · doi:10.1111/fcp.12210
  43. 10.1371/journal.pone.0076499 · DOI
  44. Delcourt N., 2017, Recreational antitussive and antihistamine drug poisoning in adolescents and young adults reported to a French Poison Control Center (Oral communication published as an Abstract in the Special Issue: Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, 19–21 April 2017, Rouen, France), Fundam. Clin. Pharmacol., 31, 14
  45. 10.1111/j.1472-8206.2008.00661.x · doi:10.1111/j.1472-8206.2008.00661.x

Cited by

Metadata

Authors
Jouanjus, E., Guernec, G., Lapeyre‐Mestre, M., & the French Addictovigilance Network
Venue
Fundamental & Clinical Pharmacology
Publisher
Wiley
Published
2018-04-02
Volume
32
Issue
3
Pages
306-322
ISSN
  • 0767-3981 (ISSN-L)
  • 1472-8206
OpenAlex
W2791301177
Cited by
61
References
6
FWCI
8.59
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.